beta-n-methylamino-l-alanine has been researched along with Basal Ganglia Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewin, R | 1 |
| Hugon, J; Ludolph, AC; Nunn, PB; Robertson, RC; Ross, SM; Roy, DN; Spencer, PS | 1 |
2 other study(ies) available for beta-n-methylamino-l-alanine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Environmental hypothesis for brain diseases strengthened by new data.
Topics: Amino Acids, Diamino; Animals; Basal Ganglia Diseases; Cyanobacteria Toxins; Environmental Exposure; Guam; Humans; Motor Neurons; Neuromuscular Diseases; Neurotoxins | 1987 |
Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Basal Ganglia Diseases; Cyanobacteria Toxins; Environmental Exposure; Guam; Macaca fascicularis; Male; Motor Cortex; Motor Neurons; Neural Conduction; Neuromuscular Diseases; Neurotoxins; Plants, Toxic; Spinal Cord; Substantia Nigra | 1987 |